Draft:ATPIII

ATP III (Adult Treatment Panel 3) is a set of guidelines for treating adults who have cardiovascular disease.

Risk Assessment
The guidelines are as followed:


 * 1) Determine lipoprotein levels and obtain a complete lipoprotein profile after a 9 to 12 hour fast.
 * 2) Identify if there is the presence of clinical atherosclerotic disease that equates to high risk for coronary heart disease (CHD) events (CHD risk equivalent)
 * 3) Determine presence of major risk factors (other than LDL)
 * 4) If 2+ risk factors (other than LDL) are present without CHD or CHD risk equivalent, assess 10-year (short-term) CHD risk (see Framingham tables). Three levels of 10-year risk
 * 5) Determine risk category
 * 6) Initiate therapeutic lifestyle changes (TLC) if LDL is above goal
 * 7) Consider adding drug therapy if LDL exceeds levels shown in Step 5 table
 * 8) Identify metabolic syndrome and treat, if present, after 3 months of TLC
 * 9) Treat elevated triglycerides

Current Status
ATP III was intended to be updated to ATP IV in 2011, but was postponed several times and was eventually scrapped for partner organizations to come up with their own guidelines in 2013.